Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Pilot Study Lp299v Supplementation in Chronic Heart Failure [NA]

View source ↗

Summary

A pilot study is evaluating the probiotic Lp299v as a supplement in chronic heart failure and is currently recruiting. The trial includes patients with reduced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lp299V (Lactobacillus plantarum 299v)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction | NA | Status: RECRUITING